Literature DB >> 6444222

Activation of rabbit Hageman factor by homogenates of cultured rabbit endothelial cells.

R C Wiggins, D J Loskutoff, C G Cochrane, J H Griffin, T S Edgington.   

Abstract

Rabbit Hageman factor was proteolytically cleaved and activated by a homogenate prepared from cultured rabbit endothelial cells. Cleavage of radiolabeled Hageman factor was monitored by polyacrylamide gel electrophoresis in the presence of sodium dodecyl sulfate. Endothelial cell-mediated cleavage of Hageman factor was demonstrated both in a purified system and in plasma, was time and concentration dependent, and was associated with formation of the characteristic 28,000 M(r) form of active Hageman factor. The rate of cleavage of Hageman factor was not affected by Triton X-100 (Rohm and Haas, Co., Philadelphia, Pa.), hexadimethrine bromide (Polybrene, Aldrich Chemical Co., Inc., Milwaukee, Wis.), hirudin, soybean trypsin inhibitor, or antisera to plasminogen or prekallikrein. However, cleavage was enhanced by kaolin, and was inhibited by diisopropyl-fluorophosphate. The enzyme responsible for cleavage of Hageman factor was localized to the 100,000-g-sedimentable, subcellular fraction of the endothelial cell homogenate and was relatively specific, because neither radiolabeled rabbit Factor XI nor rabbit prekallikrein were themselves proteolytically cleaved by the endothelial cell homogenate. However, when these molecules were incubated with the homogenate in the presence of Hageman factor, both Factor XI and prekallikrein were cleaved, demonstrating that Hageman factor had been activated by the endothelial cell homogenate. Furthermore, the kallikrein generated by endothelial cell homogenate-activated Hageman factor was capable of liberating kinin from high molecular weight kininogen as measured by bioassay. Cultured rabbit endothelial cells, therefore, possess the capacity to activate Hageman factor by proteolysis. This may be one mechanism for Hageman factor activation in vivo.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6444222      PMCID: PMC371355          DOI: 10.1172/JCI109651

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

1.  Angiotensin II stimulation of prostaglandin production in cultured human vascular endothelium.

Authors:  M A Gimbrone; R W Alexander
Journal:  Science       Date:  1975-07-18       Impact factor: 47.728

2.  A method of trace iodination of proteins for immunologic studies.

Authors:  P J McConahey; F J Dixon
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

3.  Studies of an activity from endothelial cells that inhibits platelet aggregation, serotonin release, and clot retraction.

Authors:  S R Saba; R G Mason
Journal:  Thromb Res       Date:  1974-12       Impact factor: 3.944

4.  Activation of purified plasma factor VII by human plasmin, plasma kallikrein, and activated components of the human intrinsic blood coagulation system.

Authors:  K Laake; B Osterud
Journal:  Thromb Res       Date:  1974-12       Impact factor: 3.944

5.  The kinin system of human plasma. V. The probable derivation of prekallikrein activator from activated Hageman factor (XIIa).

Authors:  M J Soltay; H Z Movat; A H Ozge-Anwar
Journal:  Proc Soc Exp Biol Med       Date:  1971-12

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Activation of Hageman factor in solid and fluid phases. A critical role of kallikrein.

Authors:  C G Cochrane; S D Revak; K D Wuepper
Journal:  J Exp Med       Date:  1973-12-01       Impact factor: 14.307

8.  The smooth muscle cell. II. Growth of smooth muscle in culture and formation of elastic fibers.

Authors:  R Ross
Journal:  J Cell Biol       Date:  1971-07       Impact factor: 10.539

9.  A prealbumin activator of prekallikrein. II. Derivation of activators of prekallikrein from active Hageman factor by digestion with plasmin.

Authors:  A P Kaplan; K F Austen
Journal:  J Exp Med       Date:  1971-04-01       Impact factor: 14.307

10.  Direct evidence for Hageman factor (factor XII) activation by bacterial lipopolysaccharides (endotoxins).

Authors:  D C Morrison; C G Cochrane
Journal:  J Exp Med       Date:  1974-09-01       Impact factor: 14.307

View more
  12 in total

Review 1.  Bradykinin formation. Plasma and tissue pathways and cellular interactions.

Authors:  A P Kaplan; K Joseph; Y Shibayama; Y Nakazawa; B Ghebrehiwet; S Reddigari; M Silverberg
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

2.  Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator.

Authors:  G M Rodgers; W H Kane
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

3.  The glomerular polyanion (GPA) of the rat kidney. III. Further characterization of a vaso-active serum factor which reduces GPA.

Authors:  W W Bakker; G Roskam; M J Hardonk; J T Vos; E Bleumink
Journal:  Br J Exp Pathol       Date:  1985-02

4.  Studies of four Japanese families with hereditary angioneurotic edema: simultaneous activation of plasma protease systems and exogenous triggering stimuli.

Authors:  J Kodama; K Uchida; S Yoshimura; Y Katayama; H Kushiro; C Yutani; S Funahashi; O Takamiya; Y Matsumoto; Y Ando
Journal:  Blut       Date:  1984-11

5.  Heat shock protein 90 catalyzes activation of the prekallikrein-kininogen complex in the absence of factor XII.

Authors:  Kusumam Joseph; Baby G Tholanikunnel; Allen P Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-15       Impact factor: 11.205

6.  Inhibition of the activation of Hageman factor (factor XII) by complement subcomponent C1q.

Authors:  E H Rehmus; B M Greene; B A Everson; O D Ratnoff
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

7.  Interaction of plasmin with endothelial cells.

Authors:  P I Bauer; R Machovich; K G Büki; E Csonka; S A Koch; I Horváth
Journal:  Biochem J       Date:  1984-02-15       Impact factor: 3.857

8.  The IgE-dependent release of a Hageman factor cleaving factor from human lung.

Authors:  H L Meier; B Flowers; M Silverberg; A P Kaplan; H H Newball
Journal:  Am J Pathol       Date:  1986-04       Impact factor: 4.307

9.  Interleukin-1 activation of vascular endothelium. Effects on procoagulant activity and leukocyte adhesion.

Authors:  M P Bevilacqua; J S Pober; M E Wheeler; R S Cotran; M A Gimbrone
Journal:  Am J Pathol       Date:  1985-12       Impact factor: 4.307

10.  Studies on the pathogenesis of the adult respiratory distress syndrome.

Authors:  W W McGuire; R G Spragg; A B Cohen; C G Cochrane
Journal:  J Clin Invest       Date:  1982-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.